Page last updated: 2024-08-21

dihydroergotamine and Acute Relapsing Multiple Sclerosis

dihydroergotamine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Johnson, BD; Schenkat, DH; Schulz, LT	1

Other Studies

1 other study(ies) available for dihydroergotamine and Acute Relapsing Multiple Sclerosis

Article	Year
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:7-8 Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; Female; Headache; Humans; Hypertension; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Vasoconstrictor Agents; Vasodilator Agents; Verapamil	2011

Article

Year

Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.

The Annals of pharmacotherapy, 2011, Volume: 45, Issue:7-8

Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; Female; Headache; Humans; Hypertension; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Vasoconstrictor Agents; Vasodilator Agents; Verapamil

2011